Six of the eight germline BRCA2 carriers with somatic reversion mutations had canonical BRCA-associated cancer types, including breast (n = 4), ovarian (n = 1), and prostate cancers (n = 1). This evidence concerns the gene BRCA2 and prostate cancer.